Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses

被引：33
作者：
Russell, Charles J. [1 ,2 ]
Hurwitz, Julia L. [1 ,2 ]
机构：
[1] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA
来源：
EXPERT REVIEW OF VACCINES | 2016年 / 15卷 / 02期
关键词：
Sendai virus; paramyxovirus; pediatric vaccine; respiratory tract; antibody; T cell; vaccine vector; intranasal; RESPIRATORY SYNCYTIAL VIRUS; AFRICAN-GREEN MONKEYS; M-PROTEIN BINDS; HUMAN PARAINFLUENZA; FUSION PROTEIN; COTTON RATS; NEUTRALIZING ANTIBODY; MEMBRANE-FUSION; B-CELL; PROTECTIVE IMMUNITY;
D O I：
10.1586/14760584.2016.1114418
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Human paramyxoviruses are the etiological agents for life-threatening respiratory virus infections of infants and young children. These viruses, including respiratory syncytial virus (RSV), the human parainfluenza viruses (hPIV1-4) and human metapneumovirus (hMPV), are responsible for millions of serious lower respiratory tract infections each year worldwide. There are currently no standard treatments and no licensed vaccines for any of these pathogens. Here we review research with which Sendai virus, a mouse parainfluenza virus type 1, is being advanced as a Jennerian vaccine for hPIV1 and as a backbone for RSV, hMPV and other hPIV vaccines for children.
引用
收藏
页码：189 / 200
页数：12
相关论文
共 135 条
[21]   Cutting edge: Long-term B cell memory in humans after smallpox vaccination [J].
Crotty, S ;
Felgner, P ;
Davies, H ;
Glidewell, J ;
Villarreal, L ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4969-4973
[22]  
Crowe J, 2010, 7 INT RESP SYNC VIR, P142
[23]   RIBOSOMAL INITIATION FROM AN ACG CODON IN THE SENDAI VIRUS P/C MESSENGER-RNA [J].
CURRAN, J ;
KOLAKOFSKY, D .
EMBO JOURNAL, 1988, 7 (01) :245-251
[24]   A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine [J].
Dagouassat, N ;
Robillard, V ;
Haeuw, JF ;
Plotnicky-Gilquin, H ;
Power, UF ;
Corvaïa, N ;
Nguyen, T ;
Bonnefoy, JY ;
Beck, A .
VACCINE, 2001, 19 (30) :4143-4152
[25]   VIRAL CROSS-REACTIVITY AND ANTIGENIC DETERMINANTS RECOGNIZED BY HUMAN PARAINFLUENZA VIRUS TYPE 1-SPECIFIC CYTOTOXIC T-CELLS [J].
DAVE, VP ;
ALLAN, JE ;
SLOBOD, KS ;
SMITH, FS ;
RYAN, KW ;
TAKIMOTO, T ;
POWER, UF ;
PORTNER, A ;
HURWITZ, JL .
VIROLOGY, 1994, 199 (02) :376-383
[26]   Burden of Human Metapneumovirus Infection in Young Children [J].
Edwards, Kathryn M. ;
Zhu, Yuwei ;
Griffin, Marie R. ;
Weinberg, Geoffrey A. ;
Hall, Caroline B. ;
Szilagyi, Peter G. ;
Staat, Mary A. ;
Iwane, Marika ;
Prill, Mila M. ;
Williams, John V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07) :633-643
[27]   Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro [J].
Elliott, MB ;
Pryharski, KS ;
Yu, QZ ;
Parks, CL ;
Laughlin, TS ;
Gupta, CK ;
Lerch, RA ;
Randolph, VB ;
LaPierre, NA ;
Dack, KMH ;
Hancock, GE .
JOURNAL OF VIROLOGY, 2004, 78 (11) :5773-5783
[28]   A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus [J].
Fu, Yuan-Hui ;
He, Jin-Sheng ;
Wang, Xiao-Bo ;
Zheng, Xian-Xian ;
Wu, Qiang ;
Xie, Can ;
Zhang, Mei ;
Wei, Wei ;
Tang, Qian ;
Song, Jing-Dong ;
Qu, Jian-Guo ;
Hong, Tao .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 395 (01) :87-92
[29]  
FUKUMI H, 1954, Jpn J Med Sci Biol, V7, P345
[30]   RESPIRATORY VIRUS IMMUNIZATION .I. A FIELD TRIAL OF 2 INACTIVATED RESPIRATORY VIRUS VACCINES - AN AQUEOUS TRIVALENT PARAINFLUENZA VIRUS VACCINE AND AN ALUM-PRECIPITATED RESPIRATORY SYNCYTIAL VIRUS VACCINE [J].
FULGINITI, VA ;
ELLER, JJ ;
SIEBER, OF ;
JOYNER, JW ;
MINAMITANI, M ;
MEIKLEJOHN, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :435-+
12345678910